Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

MilliporeSigma™ Supelco™ Astec™ CHIRALDEX™ G-TA Capillary GC Column, df 0.12 μm

Catalog No. 111006440 Shop All MilliporeSigma Supelco Products
Click to view available options
Length (Metric):
20 m
30 m
50 m

CHIRALDEX™ G-TA is one of the top choices for the analysis of Group 1 CSPs (Surface Interactions, Complex Derivatives). It has been shown to be the most broadly-selective phase for the pharmaceutical industry, especially for the analysis of chiral intermediates and drug studies in various stages of clinical trials.

Separations occur without the inclusion mechanism and are typically faster and more efficient than most chiral stationary phases. G-TA has also been used to separate parent drug enantiomers and their metabolites. G-TA has its highest selectivity for oxygen-containing analytes like alcohols, diols and polyols as the free alcohol and as an acyl derivative; amines as acyl derivatives; amino alcohols, halogens (Cl>Br>F), amino acids, hydroxy acids, lactones, furans and pyrans. It is also highly selective for halogenated compounds.
TRUSTED_SUSTAINABILITY

Specifications

Diameter (Metric) Inner 0.25 mm
Type Capillary GC
Product Line Astec CHIRALDEX
For Use With (Application) Gas Chromatography (GC)
Film Thickness 0.12 μm
Length (Metric) 20 m
Material Fused Silica
Packing Material 2,6-di-O-pentyl-3-trifluoroacetyl derivative of γ-cyclodextrin

Astec and CHIRALDEX are registered trademarks of Sigma-Aldrich Co. LLC

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.